To assess the effectiveness of Aspirin against placebo control in patients with dukes C or high risk dukes B colorectal cancer in terms of Disease Free Survival (DFS) and Overall Survival (OS).
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
|Eligibility criteria|| |
Dukes C and High Risk Dukes B Colorectal Cancer.
|Study details|| |
This study is investigating if daily aspirin improves the outcomes for patients treated curatively for colorectal cancer.
|Further information|| |
For more information regarding this clinical trial click here.
North Shore NSW